Molecular cancer therapy for tumor suppressor p53-mutated human Cancers: Galectin-9 (hGal9) suppresses the oncogenic function of Mt-p53 (R175H and R273H) via up regulation of its target gene, 22/February/2014, 20.59

miRNA-503 regulates TAp63-γ protein levels via down regulation of its target gene, 21/February/2014, 21.03
February 21, 2014
Molecular cancer therapy for tumor suppressor p53-mutated human Cancers: Cyclosporin A (CsA), a calcineurin inhibitor and an immunosuppressive agent, suppresses the oncogenic function of Mt-p53 (R175H and R273H) via up regulation of its target gene, 22/February/2014, 21.05
February 22, 2014
Show all

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan, Molecular cancer therapy for tumor suppressor p53-mutated human Cancers: Galectin-9 (hGal9) suppresses the oncogenic function of Mt-p53 (R175H and R273H) via up regulation of its target gene, 22/February/2014, 20.59, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation

Comments are closed.